Haloperidol Does Not Activate Thrombogenic Factors in Older, Nonpsychotic Hospitalized Patients

J Clin Psychopharmacol. 2017 Aug;37(4):487-488. doi: 10.1097/JCP.0000000000000716.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antipsychotic Agents / adverse effects
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Fibrinogen / metabolism*
  • Haloperidol / adverse effects*
  • Humans
  • Osteoprotegerin / blood*
  • P-Selectin / blood*
  • Thrombosis / blood
  • Thrombosis / metabolism*
  • von Willebrand Factor / metabolism*

Substances

  • Antipsychotic Agents
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • Osteoprotegerin
  • P-Selectin
  • fibrin fragment D
  • von Willebrand Factor
  • Fibrinogen
  • Haloperidol